Target intelligence / Profile preview

NADPH oxidase 2 cytochrome b558 complex (p22phox–p47phox interface) (NOX2 (p22phox–p47phox))

Target
NOX2 (p22phox–p47phox)
Molecular classification
Enzyme, Oxidoreductase, Protein-protein interface, Multi-subunit protein complex
01

Overview

The NADPH oxidase 2 (NOX2) cytochrome b558 complex is a multi-subunit enzyme system primarily responsible for the production of reactive oxygen species (ROS) during the respiratory burst in phagocytes (UniProt P04839). The complex consists of the membrane-bound cytochrome b558—a heterodimer of gp91phox and p22phox—and several cytosolic regulatory subunits, including p47phox, p67phox, and p40phox (UniProt P13498, P14598). A critical step in the activation of NOX2 is the translocation of p47phox to the membrane, where its tandem SH3 domains bind to the proline-rich region (PRR) of p22phox (PMID: 15689570). This protein-protein interaction (PPI) serves as a molecular switch that facilitates the assembly of the active enzyme complex. Dysregulation or overactivation of this interface is linked to oxidative stress-mediated damage in cardiovascular and neurodegenerative diseases (PMID: 29153444). Consequently, the p22phox–p47phox interface is a high-priority therapeutic target for small-molecule inhibitors, such as Phox-I, designed to block ROS production by disrupting this specific assembly step (PMID: 25100793).

Other names
Cytochrome b558gp91phox-p22phox complexp47phox-p22phox interactionNCF1-CYBA interfaceNOX2 assembly interfacePhagocyte NADPH oxidase complex
02

Mechanism of action

Disruption of the protein-protein interaction between the p47phox SH3 domains and the p22phox proline-rich region, preventing the assembly and activation of the NADPH oxidase 2 complex (PMID: 25100793).

03

Biological functions

Superoxide anion generationReactive oxygen species (ROS) productionRespiratory burstInnate immune responseRedox signalingPhagocytosis
04

Disease associations

InflammationCardiovascular diseaseNeurodegenerative diseaseIschemia-reperfusion injuryAtherosclerosisHypertensionStrokeAlzheimer's disease
05

Safety considerations

Increased susceptibility to bacterial and fungal infectionsImpaired phagocytic host defensePotential for Chronic Granulomatous Disease (CGD)-like phenotypeImpaired wound healing
06

Interacting drugs

Apocynin

4 more in the full profile.

07

Biomarkers

Superoxide production levelsp47phox membrane translocationNitrotyrosine8-isoprostaneMalondialdehyde (MDA)

Beyond the preview

Go deeper on NADPH oxidase 2 cytochrome b558 complex (p22phox–p47phox interface) (NOX2 (p22phox–p47phox)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADPH oxidase 2 cytochrome b558 complex (p22phox–p47phox interface) (NOX2 (p22phox–p47phox)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call